Graphiti – fast (<1h) phenotypic AST
Bringing fast (1h) phenotypic AST using patented graphene sensing technology
Save time and lives. Perform fast and highly parallelized AST on single cell level.
- Antimicrobial stewardship
- Microbial diagnostics
- Infection prevention
- Antimicrobial compound/strategy
- Removal antibiotics/bacteria
- Market entry
- Marketed product
- Joint Venture
- OTHER / NA
Infectious disease area:
- North America
- South America
Looking for partners that can help validate and build our technology and business.
Graphiti is a pre start-up initiative aiming to bring fast (<1h) phenotypic Antimicrobial Susceptibility testing
Able to provide research services to (academic) hospitals, pharma discovery projects and diagnostic centers.